25 May 2013
Keywords: epitan, buys, regional, oradisc, rights, australian, pharmaceutical
Article | 14 February 2005
Australian pharmaceutical firm EpiTan has in-licensed the Australian and New Zealand rights to the OraDisc A from USA drugmaker Access ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.